Literature DB >> 23397497

Thrombotic thrombocytopenic purpura as initial and major presentation of multiple myeloma.

Xiang Xiao1, Hai-ying Zhong, Guang-sen Zhang, Ming-yang Deng.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23397497     DOI： 10.1007/s11239-013-0893-0

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  5 in total

1.  Thrombotic thrombocytopenic purpura associated with disseminated varicella zoster in a multiple myeloma patient.

Authors:  B Xu; D Ritchie
Journal:  Intern Med J       Date:  2010-12       Impact factor: 2.048

2.  Thrombotic thrombocytopenic purpura associated with renal failure after autologous transplantation for multiple myeloma successfully treated with rituximab.

Authors:  Elisa Gallerani; Erika Lerch; Elena Romagnani; Anastasios Stathis; Greta Giardelli; Hugo Zwhalen; Claudio Marone; Franco Cavalli
Journal:  Eur J Haematol       Date:  2006-10-17       Impact factor: 2.997

Review 3.  Multiple myeloma presenting with a fever of unknown origin and development of thrombotic thrombocytopenic purpura post-bortezomib.

Authors:  H Moore; K Romeril
Journal:  Intern Med J       Date:  2011-04       Impact factor: 2.048

4.  TTP disease course is independent of myeloma treatment and response.

Authors:  Craig C Hofmeister; Ming Jin; Spero R Cataland; Don M Benson; Haifeng M Wu
Journal:  Am J Hematol       Date:  2010-04       Impact factor: 10.047

5.  Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.

Authors:  Marie Scully; Beverley J Hunt; Sylvia Benjamin; Ri Liesner; Peter Rose; Flora Peyvandi; Betty Cheung; Samuel J Machin
Journal:  Br J Haematol       Date:  2012-05-25       Impact factor: 6.998
  5 in total
  4 in total

Review 1.  Paraprotein-Related Kidney Disease: Glomerular Diseases Associated with Paraproteinemias.

Authors:  Shveta S Motwani; Leal Herlitz; Divya Monga; Kenar D Jhaveri; Albert Q Lam
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-15       Impact factor: 8.237

2.  Drug-Induced Thrombotic Microangiopathy due to Cumulative Toxicity of Ixazomib.

Authors:  Suheil Albert Atallah-Yunes; Myat Han Soe
Journal:  Case Rep Hematol       Date:  2018-07-03

3.  Renal and pulmonary thrombotic microangiopathy triggered by proteasome-inhibitor therapy in patient with smoldering myeloma: A renal biopsy and autopsy case report.

Authors:  Clarissa A Cassol; Michael P A Williams; Tiffany N Caza; Sophia Rodriguez
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

Review 4.  The role of VWF/FVIII in thrombosis and cancer progression in multiple myeloma and other hematological malignancies.

Authors:  Claire Comerford; Siobhan Glavey; John Quinn; Jamie M O'Sullivan
Journal:  J Thromb Haemost       Date:  2022-06-23       Impact factor: 16.036
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.